Startseite UR
Publikationen von 0000-0001-5252-287X
(ORCID: 0000-0001-5252-287X)
 | Eine Stufe nach oben |
Anzahl der Einträge: 14.
2026
Harrer, Dennis Christoph 
, Lüke, Florian , Pukrop, Tobias , Ghibelli, Lina, Reichle, Albrecht und Heudobler, Daniel
(2026)
Genome agnostic, multi-level non-oncogene addiction-based systems pharmacology for rescuing metastatic relapsed/refractory neoplasias.
Frontiers in Pharmacology 17.
Harrer, Dennis Christoph , Lüke, Florian , Pukrop, Tobias , Reichle, Albrecht und Heudobler, Daniel
(2026)
Genome Agnostic Reprogramming of Acute Myelocytic Leukemia Hallmarks by Targeting Non-Oncogene Addictions with Azacitidine Plus Pioglitazone and All-Trans Retinoic Acid.
International Journal of Molecular Sciences 27 (2), S. 1067.
Scheiter, Alexander , Mellin, Simon, Keil, Felix , Meier, Johannes, Heudobler, Daniel , Brummer, Christina, Einhell, Sabine , Zwicker, Benjamin, Wutzlhofer, Elena, Hierl, Frederik, Klemm, Sophie, Lüftl, Elena, Schneider, Tom, Perl, Markus, Klier-Richter, Margit, Immel, Alexander, Kaltofen, Till , Grube, Matthias, Bumes, Elisabeth , Seitz, Stephan, Schulz, Christian , Haferkamp, Sebastian , Drexler, Konstantin , Troeger, Anja, Steger, Felix, Schlosser-Hupf, Sophie, Tews, Hauke Christian, Kandulski, Arne , Wohlfart, Kristina, Erber, Ramona , Schönbuchner, Ines, Lessel, Davor , Schnabel, Marco J., Sedlmeier, Anja M. , Klinkhammer-Schalke, Monika, Maurer, Julia , Calvisi, Diego F. , Pukrop, Tobias , Kaiser, Ulrich , Hirsch, Daniela, Dietmaier, Wolfgang, Evert, Matthias, Lüke, Florian und Utpatel, Kirsten
(2026)
Supplementary biomarker testing in molecular tumor boards increases actionable therapy recommendations: a prospective real-world study of 658 patients.
BMC Medicine 24 (1).
2025
Bernardi, Christine , Wolff, Daniel , Lüke, Florian , Hies, Johannes, Horn, Ruth, Seitz, Frederike, Heudobler, Daniel , Herr, Wolfgang und Herrmann, Anne
(2025)
How to improve informed consent processes in clinical trials with cancer patients: a qualitative analysis of multidisciplinary experts’ perspectives.
BMC Medical Ethics 26 (1).
Kaiser, Ulrich , Evert, Katja , Vehling-Kaiser, Ursula, Lüke, Florian , Herr, Wolfgang und Rechenmacher, Michael
(2025)
Experts’ attitudes towards ‘targeted autopsies’ using qualitative interviews in a medical network in Germany.
BMJ Open 15 (10), e098127.
Proescholdt, Martin A. , Araceli, Tommaso, Schebesch, Karl-Michael, Doenitz, Christian, Wendl, Christina, Evert, Katja , Noeva, Ekaterina, Hoehne, Julius, Riemenschneider, Markus J., Hirsch, Daniela , Schmidt, Nils Ole , Sparrer, Daniela, Lüke, Florian , Heudobler, Daniel , Pukrop, Tobias und Blazquez, Raquel
(2025)
MetInfilt: A prospective trial highlighting the importance of the histological growth pattern in brain metastases.
Translational Oncology 60, S. 102480.
Harrer, Dennis Christoph , Lüke, Florian , Pukrop, Tobias , Ghibelli, Lina, Reichle, Albrecht und Heudobler, Daniel
(2025)
MEPED as salvage therapy for relapsed/refractory Hodgkin’s lymphoma incorporating edited non-oncogene addiction: mTOR as a bottleneck.
Frontiers in Pharmacology 16.
2024
Bernardi, Christine, Wolff, Daniel , Lüke, Florian , Hies, Johannes, Hallowell, Nina, Horn, Ruth, Seitz, Frederike, Heudobler, Daniel und Hermann-Johns, Anne
(2024)
“Uninformed consent” in clinical trials with cancer patients: A qualitative analysis of patients’ and support persons’ communication experiences and needs.
Patient Education and Counseling 122, S. 108144.
Harrer, Dennis Christoph , Lüke, Florian , Pukrop, Tobias , Ghibelli, Lina, Gerner, Christopher , Reichle, Albrecht und Heudobler, Daniel
(2024)
Peroxisome proliferator-activated receptorα/γ agonist pioglitazone for rescuing relapsed or refractory neoplasias by unlocking phenotypic plasticity.
Frontiers in Oncology 13.
2023
Harrer, Dennis Christoph , Lüke, Florian , Pukrop, Tobias , Ghibelli, Lina, Reichle, Albrecht und Heudobler, Daniel
(2023)
Addressing Genetic Tumor Heterogeneity, Post-Therapy Metastatic Spread, Cancer Repopulation, and Development of Acquired Tumor Cell Resistance.
Cancers 16 (1), S. 180.
2022
Lüke, Florian , Harrer, Dennis Christoph, Pantziarka, Pan , Pukrop, Tobias , Ghibelli, Lina, Gerner, Christopher , Reichle, Albrecht und Heudobler, Daniel
(2022)
Drug Repurposing by Tumor Tissue Editing.
Frontiers in Oncology 2022 (12), S. 900985.
Heudobler, Daniel, Harrer, Dennis Christoph, Lüke, Florian , Einspieler, Ingo, Menhart, Karin, Hellwig, Dirk , Utpatel, Kirsten , Herr, Wolfgang und Reichle, Albrecht
(2022)
Case Report: Extramedullary Acute Promyelocytic Leukemia: An Unusual Case and Mini-Review of the Literature.
Frontiers in Oncology 2022 (12), S. 1-7.
2021
Gerthofer, Valeria, Scheiter, Alexander , Lüke, Florian , Keil, Felix , Utpatel, Kirsten , Pöhmerer, Laura-Maria-Giovanna, Seitz, Johannes, Niessen, Christoph, Ignatov, Atanas , Dietmaier, Wolfgang, Calvisi, Diego F., Evert, Matthias, Ortmann, Olaf und Seitz, Stephan
(2021)
STRN-ALK Fusion in a Case of Malignant Peritoneal Mesothelioma: Mixed Response to Crizotinib, Mode of Resistance, and Brigatinib Sequential Therapy.
JCO Precision Oncology 2021 (5), S. 1507-1513.
2020
Lüke, Florian , Orsó, Evelyn , Kirsten, Jana, Poeck, Hendrik, Grube, Matthias, Wolff, Daniel, Burkhardt, Ralph , Lunz, Dirk, Lubnow, Matthias, Schmidt, Barbara, Hitzenbichler, Florian, Hanses, Frank, Salzberger, Bernd , Evert, Matthias, Herr, Wolfgang, Brochhausen, Christoph, Pukrop, Tobias, Reichle, Albrecht und Heudobler, Daniel
(2020)
Coronavirus disease 2019 induces multi‐lineage, morphologic changes in peripheral blood cells.
eJHaem 1 (1), S. 376-383.
Universitätsbibliothek
Publikationsserver
Kontakt:
Publizieren: oa@ur.de
0941 943 -4239 oder -69394
Dissertationen: dissertationen@ur.de
0941 943 -3904
Forschungsdaten: datahub@ur.de
0941 943 -5707